BIOPHARMX CORP's ticker is BPMX and the CUSIP is 09072X101. A total of 23 filers reported holding BIOPHARMX CORP in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $403,000 | -18.4% | 4,584,615 | 0.0% | 0.00% | – |
Q4 2018 | $494,000 | -73.3% | 4,584,615 | -53.0% | 0.00% | -100.0% |
Q3 2018 | $1,852,000 | -14.0% | 9,749,615 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $2,153,000 | -4.4% | 9,749,615 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $2,252,000 | +109.7% | 9,749,615 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $1,074,000 | -61.5% | 9,749,615 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $2,788,000 | -38.7% | 9,749,615 | +2.6% | 0.00% | -50.0% |
Q2 2017 | $4,550,000 | -5.1% | 9,499,615 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $4,797,000 | +35.0% | 9,499,615 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $3,553,000 | +24.9% | 9,499,615 | +85.4% | 0.00% | +100.0% |
Q3 2016 | $2,844,000 | -5.7% | 5,124,615 | +10.4% | 0.00% | -50.0% |
Q2 2016 | $3,016,000 | -40.4% | 4,640,000 | 0.0% | 0.00% | -33.3% |
Q1 2016 | $5,058,000 | -10.1% | 4,640,000 | +13.2% | 0.00% | 0.0% |
Q4 2015 | $5,629,000 | – | 4,100,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vivo Capital, LLC | 16,128,515 | $1,419,000 | 0.14% |
FRG Family Wealth Advisors LLC | 30,000 | $3,000 | 0.00% |
UBS Group AG | 38,029 | $3,000 | 0.00% |
OPPENHEIMER & CO INC | 35,000 | $3,000 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 671,686 | $59,000 | 0.00% |
BlackRock Inc. | 6,033 | $1,000 | 0.00% |
LPL Financial LLC | 40,000 | $4,000 | 0.00% |
Citadel Advisors | 413,489 | $36,000 | 0.00% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 12,264 | $1,000 | 0.00% |
TWO SIGMA SECURITIES, LLC | 137,625 | $12,000 | 0.00% |